• Written by: (Investorideas.com newswire, breaking stock market
  • Fri, 02 Aug 2024
  •   United States

August 2, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to investing platform covering biotech and nanotechnology issues a snapshot looking at news and developments in the antiviral market, featuring NanoViricides, Inc. (NYSE American: NNVC), a development stage company that is creating special purpose nanomaterials for antiviral therapy.

Biotech Stocks in Focus (NYSE American: NNVC) (NYSE: PFE) (NYSE: GSK) (NASDAQ: MRNA)